1 / 17

State – Equity Concern « Uzpharmsanoat »

State – Equity Concern « Uzpharmsanoat » Welcomes guests and participants of Uzbek-U.S.A Business Forum. “ Investment Opportunities of the pharmaceutical industry in the Republic of Uzbekistan and prospects of cooperation with the United States of America” ” Tashkent 17-18 august 2012.

makana
Download Presentation

State – Equity Concern « Uzpharmsanoat »

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. State – Equity Concern «Uzpharmsanoat» Welcomes guests and participants of Uzbek-U.S.A Business Forum “InvestmentOpportunitiesofthepharmaceuticalindustryintheRepublicofUzbekistanand prospects of cooperation with the United States of America”” Tashkent17-18 august 2012

  2. Structure of pharmaceutical industry Enterprises for the production of medicines and medicinal products (130) Enterprises for the wholesale of medicines and medicinal products (more than 200) Scientific institutions and scientific research institute on development and production of substances, organizations on training of specialists of the high and middle classes Drugstores over 8000

  3. Ensuring the needs of population on the nomenclature of manufactured pharmaceutical products, % 3

  4. Main goals and aims of SJC “Uzpharmsanoat” Organizations of production of original and generic drugs; Saturation the market’s needs with high quality, export-oriented, accessible drugs; Matching national production with international standards quality control ISO, GMP; Organizationtoattractforeigninvestmenttocreatenewproductionsociallyimportantgroupsofdrugs; Organisationofexportofmedicinalproductsandmedicalproducts 4

  5. Provision of pharmaceutical market of Uzbekistan • The volume of pharmaceutical market in 2011 totaled more than 700.0 million USD. • Share of national producers accounted for 22% or 150.0 mln USD.

  6. Opportunities for export to bordering countries Knowing the location of Uzbekistan should be noted that the export potential is great as, for example: Kazakhstan imports annually about 600 million USD; Tajikistan is approximately 116 million USD;Kyrgyzstan is approximately 100 million USD;Turkmenistan - 140 million USD;Afghanistan - 200 million USD.

  7. The ratio of registered medicines in the Republic of Uzbekistan on 01.01.2012g. Total - 6236 items

  8. The list of U.S. companies and Pharmaceutical groups

  9. The list of U.S. companies and Pharmaceutical groups

  10. The capital structure of pharmaceutical companies (in mln. USD)

  11. Exempt of VAT and custom duties: Import of raw materials for pharmaceutical production; Technologic equipment; Settled technologic equipment is exempt of property taxfor 2 years. Benefits and insensitive for foreign investors 11

  12. Cooperation with US companies Together with the company «Merck» arranged market research of pharmaceutical market to identify potential therapeutic areas, with insufficient drug level to supply through local production. The company «Con Technologies Corporation» has expressed a desire to participate in the project for the production of pharmaceutical products in the SIZ "Angren" 12

  13. «The organization of production of preparations for treatment of oncologic diseases» Total cost of the project of-28 mln.USD; Annual production capacity – 1,0mlnconventional units. in a year; Payback period – 6 years; Profitability – 29 %; Created workplaces – 100. • The proposed location - SIZ "Angren“ • Note: could be changedafter consultation with the foreign partner

  14. «The organization of production of preparations for treatment of cardiovascular diseases» Total cost of the project of-25 mln.USD; - Annual production capacity – 2mln. packsin a year; Payback period – 6 years; Profitability – 27 %; Created workplaces – 100. • The proposed location - SIZ "Angren“ • Note: could be changedafter consultation with the foreign partner

  15. «The organization of production of preparations for treatment of endocrine diseases» Total cost of the project of-12mln.USD; Annual capacity – 5,0 mln. conventional units. in a year; Payback period – 5 years; Profitability – 20 %; Created workplaces – 50. . • The proposed location - SIZ "Angren“ • Note: could be changedafter consultation with the foreign partner

  16. «The organization of production of preparations for treatment of psychoneurological diseases» Total cost of the project of-30 mln.USD; Annual capacity – 15,0 mln conventional units. in a year; Payback period – 5 years; Profitability – 27 %; Created workplaces – 50. . • The proposed location - SIZ "Angren“ • Note: could be changedafter consultation with the foreign partner

  17. Thank you! www.uzpharmsanoat.uz e-mail: pochta@uzpharmsanoat.uz; ufs@sarkor.uz

More Related